{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:44:21Z","timestamp":1782920661790,"version":"3.54.5"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["22ck0106644s0202"],"award-info":[{"award-number":["22ck0106644s0202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221514h0002"],"award-info":[{"award-number":["23ama221514h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011746","name":"NOVARTIS Foundation (Japan) for the Promotion of Science (NOVARTIS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24360"],"award-info":[{"award-number":["23K24360"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K22128"],"award-info":[{"award-number":["24K22128"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22KK0127"],"award-info":[{"award-number":["22KK0127"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19216"],"award-info":[{"award-number":["24K19216"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ0970"],"award-info":[{"award-number":["24KJ0970"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ0970"],"award-info":[{"award-number":["24KJ0970"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H03537"],"award-info":[{"award-number":["20H03537"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K19216"],"award-info":[{"award-number":["24K19216"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K22128"],"award-info":[{"award-number":["24K22128"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005927","name":"Daiichi Sankyo Foundation of Life Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005927","id-type":"DOI","asserted-by":"publisher"}]},{"name":"research grants from The Japanese Society of Hematology"},{"name":"JST SPRING (JPMJSP2108, MN) from the Graduate School of Frontier Sciences, The University of Tokyo."},{"name":"a research grant from The Japanese Society of Hematology"},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41375-026-02977-4","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:46:00Z","timestamp":1777963560000},"page":"1454-1466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MECOM promotes leukemia progression and inhibits mast cell differentiation through functional competition with GATA2"],"prefix":"10.1038","volume":"40","author":[{"given":"Kohei","family":"Iida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayuko","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakushin","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6116-7996","authenticated-orcid":false,"given":"Shuhei","family":"Asada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-3307","authenticated-orcid":false,"given":"Tomoya","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Yabushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8538-0916","authenticated-orcid":false,"given":"Yosuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-1767","authenticated-orcid":false,"given":"Toshio","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9339-1826","authenticated-orcid":false,"given":"Susumu","family":"Goyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"2977_CR1","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1349-7006.2009.01152.x","volume":"100","author":"S Goyama","year":"2009","unstructured":"Goyama S, Kurokawa M. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies. Cancer Sci. 2009;100:990\u20135.","journal-title":"Cancer Sci"},{"key":"2977_CR2","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12185-010-0618-5","volume":"91","author":"S Goyama","year":"2010","unstructured":"Goyama S, Kurokawa M. Evi-1 as a critical regulator of leukemic cells. Int J Hematol. 2010;91:753\u20137.","journal-title":"Int J Hematol"},{"key":"2977_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.stem.2008.06.002","volume":"3","author":"S Goyama","year":"2008","unstructured":"Goyama S, Yamamoto G, Shimabe M, Sato T, Ichikawa M, Ogawa S, et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell. 2008;3:207\u201320.","journal-title":"Cell Stem Cell"},{"key":"2977_CR4","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1084\/jem.20110447","volume":"208","author":"K Kataoka","year":"2011","unstructured":"Kataoka K, Sato T, Yoshimi A, Goyama S, Tsuruta T, Kobayashi H, et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med. 2011;208:2402\u201315.","journal-title":"J Exp Med"},{"key":"2977_CR5","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/sj.emboj.7600679","volume":"24","author":"H Yuasa","year":"2005","unstructured":"Yuasa H, Oike Y, Iwama A, Nishikata I, Sugiyama D, Perkins A, et al. Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through Gata-2 expression. Embo J. 2005;24:1976\u201387.","journal-title":"Embo J"},{"key":"2977_CR6","doi-asserted-by":"publisher","first-page":"3937","DOI":"10.1073\/pnas.89.9.3937","volume":"89","author":"K Morishita","year":"1992","unstructured":"Morishita K, Parganas E, Willman C, Whittaker M, Drabkin H, Oval J, et al. Activation Of Evi1 gene-expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band-3q26. Proc Natl Acad Sci USA. 1992;89:3937\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2977_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","volume":"101","author":"S Van Doorn-Khosrovani","year":"2003","unstructured":"Van Doorn-Khosrovani S, Erpelinck C, Van Putten W, Valk P, De Luytgaarde S, Hack R, et al. High Evi1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood. 2003;101:837\u201345.","journal-title":"Blood"},{"key":"2977_CR8","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1200\/JCO.2010.29.2771","volume":"28","author":"S Lugthart","year":"2010","unstructured":"Lugthart S, Gr\u00f6schel S, Beverloo H, Kayser S, Valk P, Van Zelderen-Bhola S, et al. Clinical, molecular, and prognostic significance of who type Inv(3)(Q21q26.2)\/T(3;3)(Q21;Q26.2) and various other 3q abnormalities in acute myeloid leukemia. J Clin Oncol. 2010;28:3890\u20138.","journal-title":"J Clin Oncol"},{"key":"2977_CR9","first-page":"2665","volume":"11","author":"A Perkins","year":"1991","unstructured":"Perkins A, Fishel R, Jenkins N, Copeland N. Evi-1, A murine zinc finger protooncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol. 1991;11:2665\u201374.","journal-title":"Mol Cell Biol"},{"key":"2977_CR10","first-page":"1575","volume":"9","author":"T Funabiki","year":"1994","unstructured":"Funabiki T, Kreider B, Ihle J. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of gaagatgag. Oncogene. 1994;9:1575\u201381.","journal-title":"Oncogene"},{"key":"2977_CR11","first-page":"4291","volume":"13","author":"R Delwel","year":"1993","unstructured":"Delwel R, Funabiki T, Kreider B, Morishita K, Ihle J. 4 of the 7 zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to Ga(C\/T)Aaga(T\/C)Aagataa. Mol Cell Biol. 1993;13:4291\u2013300.","journal-title":"Mol Cell Biol"},{"key":"2977_CR12","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/j.1349-7006.2008.00842.x","volume":"99","author":"T Sato","year":"2008","unstructured":"Sato T, Goyama S, Nitta E, Takeshita M, Yoshimi M, Nakagawa M, et al. Evi-1 Promotes para-aortic splanchnopleural hematopoiesis through up-regulation of gata-2 and repression of Tgf-\u03b2 signaling. Cancer Sci. 2008;99:1407\u201313.","journal-title":"Cancer Sci"},{"key":"2977_CR13","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1038\/onc.2009.288","volume":"28","author":"M Shimabe","year":"2009","unstructured":"Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, Imai Y, et al. Pbx1 is a downstream target of Evi-1 in hematopoietic stem\/progenitors and leukemic cells. Oncogene. 2009;28:4364\u201374.","journal-title":"Oncogene"},{"key":"2977_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1182\/bloodadvances.2022008018","volume":"7","author":"Y Masamoto","year":"2023","unstructured":"Masamoto Y, Chiba A, Mizuno H, Hino T, Hayashida H, Sato T, et al. Evi1 exerts distinct roles in AmL via Erg and cyclin D1 promoting a chemoresistant and immune-suppressive environment. Blood Adv. 2023;7:1577\u201393.","journal-title":"Blood Adv"},{"key":"2977_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood.2022016592","volume":"141","author":"J Schmoellerl","year":"2023","unstructured":"Schmoellerl J, Barbosa I, Minnich M, Andersch F, Smeenk L, Havermans M, et al. Evi1 drives leukemogenesis through aberrant ERG activation. Blood. 2023;141:453\u201366.","journal-title":"Blood"},{"key":"2977_CR16","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1182\/blood-2009-12-261602","volume":"117","author":"A Yoshimi","year":"2011","unstructured":"Yoshimi A, Goyama S, Watanabe-Okochi N, Yoshiki Y, Nannya Y, Nitta E, et al. Evi1 represses pten expression and activates Pi3k\/Akt\/Mtor via interactions with polycomb proteins. Blood. 2011;117:3617\u201328.","journal-title":"Blood"},{"key":"2977_CR17","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1182\/blood.V97.9.2815","volume":"97","author":"K Izutsu","year":"2001","unstructured":"Izutsu K, Kurokawa M, Imai Y, Maki K, Mitani K, Hirai H. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor \u03b2 signaling. Blood. 2001;97:2815\u201322.","journal-title":"Blood"},{"key":"2977_CR18","doi-asserted-by":"crossref","unstructured":"Pastoors D, Havermans M, Mulet-L\u00e1zaro R, Brian D, Noort W, Grasel J, et al. Oncogene Evi1 drives acute myeloid leukemia via a targetable interaction with Ctbp2. Sci Adv. 2024;10:eadk9076.","DOI":"10.1126\/sciadv.adk9076"},{"key":"2977_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/leu.2009.202","volume":"24","author":"S Goyama","year":"2010","unstructured":"Goyama S, Nitta E, Yoshino T, Kako S, Watanabe-Okochi N, Shimabe M, et al. Evi-1 interacts with histone methyltransferases Suv39h1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia. 2010;24:81\u20138.","journal-title":"Leukemia"},{"key":"2977_CR20","doi-asserted-by":"publisher","first-page":"25834","DOI":"10.1074\/jbc.M102343200","volume":"276","author":"S Palmer","year":"2001","unstructured":"Palmer S, Brouillet J, Kilbey A, Fulton R, Walker M, Crossley M, et al. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins. J Biol Chem. 2001;276:25834\u201340.","journal-title":"J Biol Chem"},{"key":"2977_CR21","doi-asserted-by":"crossref","unstructured":"Li Y, Gao J, Kamran M, Harmacek L, Danhorn T, Leach S, et al. Gata2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers. Nat Commun. 2021;12:494.","DOI":"10.1101\/2020.09.16.300327"},{"key":"2977_CR22","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1182\/blood-2014-11-612465","volume":"125","author":"S Ohmori","year":"2015","unstructured":"Ohmori S, Moriguchi T, Noguchi Y, Ikeda M, Kobayashi K, Tomaru N, et al. Gata2 is critical for the maintenance of cellular identity in differentiated mast cells derived from mouse bone marrow. Blood. 2015;125:3306\u201315.","journal-title":"Blood"},{"key":"2977_CR23","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1084\/jem.20130751","volume":"210","author":"E De Pater","year":"2013","unstructured":"De Pater E, Kaimakis P, Vink C, Yokomizo T, Yamada-Inagawa T, Van Der Linden R, et al. Gata2 is required for HSC generation and survival. J Exp Med. 2013;210:2843\u201350.","journal-title":"J Exp Med"},{"key":"2977_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20031556","volume":"200","author":"K Ling","year":"2004","unstructured":"Ling K, Ottersbach K, Van Hamburg J, Oziemlak A, Tsai F, Orkin S, et al. Gata-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells. J Exp Med. 2004;200:871\u201382.","journal-title":"J Exp Med"},{"key":"2977_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0301-472X(00)00553-1","volume":"28","author":"P Ikonomi","year":"2000","unstructured":"Ikonomi P, Rivera C, Riordan M, Washington G, Schechter A, Noguchi C. Overexpression of Gata-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol. 2000;28:1423\u201331.","journal-title":"Exp Hematol"},{"key":"2977_CR26","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ccr.2014.02.008","volume":"25","author":"H Yamazaki","year":"2014","unstructured":"Yamazaki H, Suzuki M, Otsuki A, Shimizu R, Bresnick E, Engel J, et al. A remote Gata2 hematopoietic enhancer drives leukemogenesis in Inv(3)(Q21; Q26) by activating Evi1 expression. Cancer Cell. 2014;25:415\u201327.","journal-title":"Cancer Cell"},{"key":"2977_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cell.2014.02.019","volume":"157","author":"S Gr\u00f6schel","year":"2014","unstructured":"Gr\u00f6schel S, Sanders M, Hoogenboezem R, De Wit E, Bouwman B, Erpelinck C, et al. A single oncogenic enhancer rearrangement causes concomitant Evi1 and Gata2 deregulation in leukemia. Cell. 2014;157:369\u201381.","journal-title":"Cell"},{"key":"2977_CR28","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1182\/bloodadvances.2019000978","volume":"4","author":"A Yamaoka","year":"2020","unstructured":"Yamaoka A, Suzuki M, Katayama S, Orihara D, Engel J, Yamamoto M. Evi1 and Gata2 misexpression induced by Inv(3)(Q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis. Blood Adv. 2020;4:1722\u201336.","journal-title":"Blood Adv"},{"key":"2977_CR29","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1182\/blood-2016-12-756767","volume":"130","author":"S Katayama","year":"2017","unstructured":"Katayama S, Suzuki M, Yamaoka A, Keleku-Lukwete N, Katsuoka F, Otsuki A, et al. Gata2 haploinsufficiency accelerates Evi1-driven leukemogenesis. Blood. 2017;130:908\u201319.","journal-title":"Blood"},{"key":"2977_CR30","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s10875-023-01545-0","volume":"43","author":"R Voit","year":"2023","unstructured":"Voit R, Sankaran V. Mecom deficiency: from bone marrow failure to impaired B-cell development. J Clin Immunol. 2023;43:1052\u201366.","journal-title":"J Clin Immunol"},{"key":"2977_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1182\/bloodadvances.2018016501","volume":"2","author":"M Germeshausen","year":"2018","unstructured":"Germeshausen M, Ancliff P, Estrada J, Metzler M, Ponstingl E, R\u00fctschle H, et al. Mecom-associated syndrome: a heterogeneous inherited bone marrow failure syndrome with amegakaryocytic thrombocytopenia. Blood Adv. 2018;2:586\u201396.","journal-title":"Blood Adv"},{"key":"2977_CR32","doi-asserted-by":"crossref","unstructured":"Osumi T, Tsujimoto S, Nakabayashi K, Taniguchi M, Shirai R, Yoshida M, et al. Somatic mecom mosaicism in a patient with congenital bone marrow failure without a radial abnormality. Pediatr Blood Cancer 2018;65:e26959.","DOI":"10.1002\/pbc.26959"},{"key":"2977_CR33","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.3324\/haematol.2017.178723","volume":"103","author":"T Ripperger","year":"2018","unstructured":"Ripperger T, Hofmann W, Koch J, Shirneshan K, Haase D, Wulf G, et al. Mds1 and Evi1 complex locus (Mecom): a novel candidate gene for hereditary hematological malignancies. Haematologica. 2018;103:E55\u20138.","journal-title":"Haematologica"},{"key":"2977_CR34","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ajhg.2015.10.010","volume":"97","author":"T Niihori","year":"2015","unstructured":"Niihori T, Ouchi-Uchiyama M, Sasahara Y, Kaneko T, Hashii Y, Irie M, et al. Mutations in mecom, encoding oncoprotein Evi1, cause radioulnar synostosis with amegakaryocytic thrombocytopenia. Am J Hum Genet. 2015;97:848\u201354.","journal-title":"Am J Hum Genet"},{"key":"2977_CR35","doi-asserted-by":"publisher","first-page":"E284","DOI":"10.3324\/haematol.2017.183855","volume":"103","author":"A Walne","year":"2018","unstructured":"Walne A, Tummala H, Ellison A, Cardoso S, Sidhu J, Sciuccati G, et al. Expanding the phenotypic and genetic spectrum of radioulnar synostosis-associated hematological disease. Haematologica. 2018;103:E284\u20137.","journal-title":"Haematologica"},{"key":"2977_CR36","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1182\/bloodadvances.2022008462","volume":"7","author":"K Nagai","year":"2023","unstructured":"Nagai K, Niihori T, Muto A, Hayashi Y, Abe T, Igarashi K, et al. Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces Hspcs in mice. Blood Adv. 2023;7:5409\u201320.","journal-title":"Blood Adv"},{"key":"2977_CR37","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2016-01-695759","volume":"127","author":"R Avellino","year":"2016","unstructured":"Avellino R, Havermans M, Erpelinck C, Sanders M, Hoogenboezem R, Van De Werken H, et al. An autonomous Cebpa enhancer specific for myeloid-lineage priming and neutrophilic differentiation. Blood. 2016;127:2991\u20133003.","journal-title":"Blood"},{"key":"2977_CR38","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt RJ, Chen SD, Zhou Y, Yim MJ, Swiech L, Kempton HR, et al. Crispr-Cas9 knock-in mice for genome editing and cancer modeling. Cell. 2014;159:440\u201355.","journal-title":"Cell"},{"key":"2977_CR39","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0301-472X(03)00260-1","volume":"31","author":"T Kitamura","year":"2003","unstructured":"Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol. 2003;31:1007\u201314.","journal-title":"Exp Hematol"},{"key":"2977_CR40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/leu.2015.275","volume":"30","author":"S Goyama","year":"2016","unstructured":"Goyama S, Schibler J, Gasilina A, Shrestha M, Lin S, Link KA, et al. Ubash3b\/Sts-1-Cbl axis regulates myeloid proliferation in human preleukemia induced by Aml1-Eto. Leukemia. 2016;30:728\u201339.","journal-title":"Leukemia"},{"key":"2977_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Landmead B, Salzberg SL. Hisat: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u2013U121.","journal-title":"Nat Methods"},{"key":"2977_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. Edger: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"2977_CR43","doi-asserted-by":"crossref","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genom Biol 2009;10:R25.","DOI":"10.1186\/gb-2009-10-3-r25"},{"key":"2977_CR44","doi-asserted-by":"crossref","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based analysis of chip-seq (Macs). Genom Biol. 2008;9:R137.","DOI":"10.1186\/gb-2008-9-9-r137"},{"key":"2977_CR45","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"GC Yu","year":"2015","unstructured":"Yu GC, Wang LG, He QY. Chipseeker: an R\/bioconductor package for chip peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382\u20133.","journal-title":"Bioinformatics"},{"key":"2977_CR46","doi-asserted-by":"publisher","first-page":"W160","DOI":"10.1093\/nar\/gkw257","volume":"44","author":"F Ram\u00edrez","year":"2016","unstructured":"Ram\u00edrez F, Ryan DP, Gr\u00fcning B, Bhardwaj V, Kilpert F, Richter AS, et al. Deeptools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44:W160\u20135.","journal-title":"Nucleic Acids Res"},{"key":"2977_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"2977_CR48","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38:576\u201389.","journal-title":"Mol Cell"},{"key":"2977_CR49","doi-asserted-by":"publisher","first-page":"6165","DOI":"10.1038\/sj.onc.1208754","volume":"24","author":"E Nitta","year":"2005","unstructured":"Nitta E, Izutsu K, Yamaguchi Y, Imai Y, Ogawa S, Chiba S, et al. Oligomerization of Evi-1, regulated by the pr domain, contributes to recruitment of corepressor Ctbp. Oncogene. 2005;24:6165\u201373.","journal-title":"Oncogene"},{"key":"2977_CR50","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","volume":"118","author":"A Hsu","year":"2011","unstructured":"Hsu A, Sampaio E, Khan J, Calvo K, Lemieux J, Patel S, et al. Mutations in Gata2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (Monomac) syndrome. Blood. 2011;118:2653\u20135.","journal-title":"Blood"},{"key":"2977_CR51","doi-asserted-by":"publisher","first-page":"23626","DOI":"10.1073\/pnas.2003228117","volume":"117","author":"J Hsu","year":"2020","unstructured":"Hsu J, Huang H, Lee C, Choudhuri A, Wilson N, Abraham B, et al. Chd7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation. Proc Natl Acad Sci USA. 2020;117:23626\u201335.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2977_CR52","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.stem.2021.10.002","volume":"29","author":"K Sch\u00f6nberger","year":"2022","unstructured":"Sch\u00f6nberger K, Obier N, Romero-Mulero M, Cauchy P, Mess J, Pavlovich P, et al. Multilayer omics analysis reveals a non-classical retinoic acid signaling axis that regulates hematopoietic stem cell identity. Cell Stem Cell. 2022;29:131.","journal-title":"Cell Stem Cell"},{"key":"2977_CR53","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1158\/0008-5472.CAN-14-3625","volume":"75","author":"C Vitali","year":"2015","unstructured":"Vitali C, Bassani C, Chiodoni C, Fellini E, Guarnotta C, Miotti S, et al. Socs2 controls proliferation and stemness of hematopoietic cells under stress conditions, and its deregulation marks unfavorable acute leukemias. Cancer Res. 2015;75:2387\u201399.","journal-title":"Cancer Res"},{"key":"2977_CR54","doi-asserted-by":"crossref","unstructured":"Zhang Y, D\u00e9pond M, He L, Foudi A, Kwarteng E, Lauret E, et al. CXCR4\/CXCL12 axis counteracts hematopoietic stem cell exhaustion through selective protection against oxidative stress. Sci Rep. 2016;6:37827.","DOI":"10.1038\/srep37827"},{"key":"2977_CR55","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41375-019-0694-3","volume":"34","author":"AI Antar","year":"2020","unstructured":"Antar AI, Otrock ZK, Jabbour E, Mohty M, Bazarbachi A. Flt3 inhibitors in acute myeloid leukemia: ten frequently asked questions. Leukemia. 2020;34:682\u201396.","journal-title":"Leukemia"},{"key":"2977_CR56","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41375-023-01880-6","volume":"37","author":"Y Lu","year":"2023","unstructured":"Lu Y, Yang L, Shen M, Zhang Z, Wang S, Chen F, et al. Tespa1 facilitates hematopoietic and leukemic stem cell maintenance by restricting C-Myc degradation. Leukemia. 2023;37:1039\u201347.","journal-title":"Leukemia"},{"key":"2977_CR57","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1182\/blood-2006-02-004184","volume":"108","author":"B Dumitriu","year":"2006","unstructured":"Dumitriu B, Patrick M, Petschek J, Cherukuri S, Klingmuller U, Fox P, et al. Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development. Blood. 2006;108:1198\u2013207.","journal-title":"Blood"},{"key":"2977_CR58","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.thromres.2006.03.007","volume":"119","author":"M Ikeda","year":"2007","unstructured":"Ikeda M. Characterization of functional P2x1 receptors in mouse megakaryocytes. Thromb Res. 2007;119:343\u201353.","journal-title":"Thromb Res"},{"key":"2977_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0925-4773(97)00057-9","volume":"65","author":"P Hoyt","year":"1997","unstructured":"Hoyt P, Bartholomew C, Davis A, Yutzey K, Gamer L, Potter S, et al. The evil proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev. 1997;65:55\u201370.","journal-title":"Mech Dev"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02977-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02977-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:49:02Z","timestamp":1782917342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-02977-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2977"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-02977-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.20.594903","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-4521321\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}